Sanofi says its vaccine won’t need supercooling
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
January 31, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, JANUARY 31, 2023
Sanofi says its vaccine won’t need supercooling

Coronavirus chronicle

BSS/AFP
16 November, 2020, 09:50 am
Last modified: 16 November, 2020, 09:55 am

Related News

  • Incepta Pharma abandons Covid vaccine plan
  • European regulator recommends Pfizer's Omicron booster for children
  • Cancer vaccine may be ready by 2030, say founders of Covid-19 vaccine maker BioNTech
  • US donates 10 million more Pfizer Covid shots to Bangladesh
  • AstraZeneca, Moderna recipients to receive Pfizer vaccine to mix-and-match

Sanofi says its vaccine won’t need supercooling

The companies said they expect to supply up to 50 million vaccine doses globally in 2020, and up to 1.3 billion doses in 2021

BSS/AFP
16 November, 2020, 09:50 am
Last modified: 16 November, 2020, 09:55 am
A man wearing a protective face mask walks past the logo of Sanofi at the company's headquarters in Paris, France, April 24, 2020/ Reuters
A man wearing a protective face mask walks past the logo of Sanofi at the company's headquarters in Paris, France, April 24, 2020/ Reuters

The coronavirus vaccine being developed by Sanofi won't need to be super-cooled and a normal refrigerator will suffice, the Paris-based drugmaker's France chief Olivier Bogillot said Sunday.

His comments came days after American pharmaceutical giant Pfizer and its German partner BioNTech announced that their vaccine had proven 90 percent effective in preventing Covid-19 infections in ongoing Phase 3 trials involving more than 40,000 people.

The companies said they expect to supply up to 50 million vaccine doses globally in 2020, and up to 1.3 billion doses in 2021.

However, Pfizer's vaccine must be stored at -70 degrees Celsius (-94 degrees Fahrenheit) or else it falls apart, well beyond the capability of most hospital freezers let alone domestic appliances.

Rachel Silverman, a policy fellow at the Center for Global Development, has already warned that maintaining the Pfizer vaccine's "ultra-cold chain" from factory to patients' arms constitutes "an enormous logistical challenge even in the West".

"Our vaccine will be like the 'flu vaccine, you can keep it in your refrigerator," this avoiding the problem, Bogillot told the CNews channel.

"This will be an advantage for some countries," he added.

The Sanofi vaccine, one of many in development, will be available for distribution next June, Bogillot added.

The results of the Phase 2 tests, involving hundreds of people, will be made public in early December, he added. If those results are positive then Phase 3 trials involving thousands of people will begin, alongside mass production.

Eleven of the vaccines under development have already begun Phase 3 trials.

The Pfizer vaccine is "a little more advanced" in the development process, said Bogillot, but "one laboratory is not going to be able to supply the doses for the whole planet.

"We will need to have several winners at the end of this race."

The Sanofi product will also be made avaiable at an "affordable" price he said, without giving details.

Top News

Olivier Bogillot / Sanofi France / Sanofi / Coronavirus Vaccine / covid-19 vaccine / Freezer / Pfizer coronavirus vaccine / BionTech Covid-19 Vaccine / BioNTech-Pfizer vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
    IMF approves Bangladesh's $4.5 billion loan proposal
  • Despite downturn 3 dozen listed firms plan Tk7,500cr investment
    Despite downturn 3 dozen listed firms plan Tk7,500cr investment
  • Mysterious resignation of SIBL chairman, addl MD
    Mysterious resignation of SIBL chairman, addl MD

MOST VIEWED

  • A nurse prepares a shot for Jonathan Halter as the German embassy begins its roll out of BioNTech COVID-19 vaccines for German expatriates at a Beijing United Family hospital in Beijing, China January 5, 2023. REUTERS/Thomas Peter/File Photo
    Covid remains a public health emergency, says WHO
  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs
  • Photo: Collected
    India launches world’s 1st intranasal Covid vaccine
  • A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  •  A medical worker checks the IV drip treatment of a patient lying on a bed in the emergency department of a hospital, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China, January 5, 2023. REUTERS/Staff
    China says Covid deaths down by nearly 80 percent

Related News

  • Incepta Pharma abandons Covid vaccine plan
  • European regulator recommends Pfizer's Omicron booster for children
  • Cancer vaccine may be ready by 2030, say founders of Covid-19 vaccine maker BioNTech
  • US donates 10 million more Pfizer Covid shots to Bangladesh
  • AstraZeneca, Moderna recipients to receive Pfizer vaccine to mix-and-match

Features

Photo: Courtesy

The Hawkers: Where minimalism meets motifs

20h | Brands
TBS illustration

Where do Shariah-compliant mutual funds stand in Bangladesh

19h | Panorama
Sketch: TBS

A subsidy war without winners

18h | Panorama
Photo: Collected

Oppo Reno 8T first look revealed!

19h | Brands

More Videos from TBS

two more factories of the country got platinum certificate.

two more factories of the country got platinum certificate.

10h | TBS Today
Iconic villains of Bollywood

Iconic villains of Bollywood

11h | TBS Entertainment
General knowledge "Gravity"

General knowledge "Gravity"

9h | Videos
Will tanks turn the tide for Ukraine?

Will tanks turn the tide for Ukraine?

10h | TBS World

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

3
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

4
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

5
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]